Patents Assigned to H. Lee Moffitt Cancer Center and Research Institute, Inc. (A Florida Non-Profit Corporation)
  • Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
    Patent number: 12201719
    Abstract: Disclosed are compositions and methods comprising the administration of pulsed dendritic cells and an immunoregulator molecule inhibitor for the treatment of cancer.
    Type: Grant
    Filed: April 27, 2023
    Date of Patent: January 21, 2025
    Assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc. (A Florida Non-Profit Corporation), VACCINEX, INC.
    Inventors: Brian Czerniecki, Krithika N. Kodumudi, Elizabeth Evans